In Vitro Evaluation of Drug–Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor
Epetraborole (EBO) is a boron-containing inhibitor of bacterial leucyl-tRNA synthetase, with potent activity against nontuberculous mycobacteria (NTM) and Gram-negative bacteria, including <i>Burkholderia pseudomallei</i>. EBO is being developed for the treatment of NTM lung disease and...
Main Authors: | Afshin Shafiee, Sanjay Chanda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/1/120 |
Similar Items
-
Insights into the Effects of Ligand Binding on Leucyl-tRNA Synthetase Inhibitors for Tuberculosis: In Silico Analysis and Isothermal Titration Calorimetry Validation
by: Zia Ur Rehman, et al.
Published: (2024-06-01) -
Aminoacyl tRNA synthetases as potential drug targets of the Panthera pathogen Babesia
by: Jyoti Chhibber-Goel, et al.
Published: (2019-10-01) -
Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis
by: Krishnendu Khan, et al.
Published: (2022-05-01) -
Leucyl-tRNA Synthetase Inhibitor, D-Norvaline, in Combination with Oxacillin, Is Effective against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Hong-Ju Lee, et al.
Published: (2022-05-01) -
The phenotypic expression of mitochondrial tRNA-mutations can be modulated by mitochondrial leucyl-tRNA synthetase and the C-terminal domain thereof.
by: Carla eGiordano, et al.
Published: (2015-03-01)